ESCRS - PO1058 - Ocular Effects (Safety) Of Intracameral Vigadexa (Moxifloxacin/Dexamethasone) In Patients Who Underwent Phacoemulsification

Ocular Effects (Safety) Of Intracameral Vigadexa (Moxifloxacin/Dexamethasone) In Patients Who Underwent Phacoemulsification

Published 2023 - 41st Congress of the ESCRS

Reference: PO1058 | Type: Free paper | DOI: 10.82333/q8hv-1x42